Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Noncytotoxic suramin as a chemosensitizer in patients with advanced non-small-cell lung cancer: a phase II study.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Noncytotoxic suramin as a chemosensitizer in patients with advanced non-small-cell lung cancer: a phase II study.
Noncytotoxic suramin as a chemosensitizer in patients with advanced non-small-cell lung cancer: a phase II study. Ann Oncol. 2008 Nov; 19(11):1903-9.
View in:
PubMed
subject areas
Adult
Adult
Aged
Aged
Antineoplastic Combined Chemotherapy Protocols
Antineoplastic Combined Chemotherapy Protocols
Carboplatin
Carboplatin
Carcinoma, Non-Small-Cell Lung
Carcinoma, Non-Small-Cell Lung
Drug Resistance, Neoplasm
Drug Resistance, Neoplasm
Drug Synergism
Drug Synergism
Female
Female
Fibroblast Growth Factor 1
Fibroblast Growth Factor 1
Fibroblast Growth Factor 2
Fibroblast Growth Factor 2
Humans
Humans
Lung Neoplasms
Lung Neoplasms
Male
Male
Middle Aged
Middle Aged
Neoplasm Staging
Neoplasm Staging
Paclitaxel
Paclitaxel
Suramin
Suramin